Cosmetic Laser Dermatology   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: San Diego CA United States

Organization Overview

First Clinical Trial
2015
NCT02454088
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cosmetic Laser Dermatology

Active Ingredients

Drugs in Phase 4 Trials (1)

tretinoin (Retin-A) (1 trial)

Drugs in Phase 2 Trials (1)

aiv001 (1 trial)

Drugs in Other Trials (3)

hydroxyapatite silica (1 trial)

silicone (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rosacea (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5